European VCs band together to improve the landscape for biotech startups

European VCs band together to improve the landscape for biotech startups

A new group, the European Life Sciences Coalition, will lobby on policies aimed to attract more investment into the life sciences industry.

European Life Sciences Coalition Launched to Enhance Investment and Competitiveness

A new European Life Sciences Coalition has been established in Brussels to address the systemic investment gaps and regulatory hurdles hindering the continent’s biotechnology sector. Formed in partnership with Invest Europe and representing firms managing over €24 billion in assets, the group aims to mobilize greater public and private capital to support the scaling of innovative companies. The initiative seeks to prevent “innovation leakage,” w…

European life sciences coalition launched to boost investment ecosystem

New group aims to address structural barriers holding back Europe’s biotech scale‑up

European VCs form coalition to garner support for homegrown biotech investing

Some of Europe's largest biotech investors are banding together in an effort to drive more private and public capital toward homegrown medicines and startups. Novo Holdings, Forbion, Sofinnova Partners, Omega Funds and a handful of ...

European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem

The European Life Sciences Coalition (ELSC), in association with Invest Europe – a new initiative to strengthen Europe’s life sciences venture capital (VC) ecosystem. The ELSC brings together leading life sciences VC firms, research institutions, and ecosystem partners to mobilise public and private capital more effectively so Europe can finance, scale, and retain its life sciences innovation at home.